An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy
CompletedOBSERVATIONAL
Enrollment
334
Participants
Timeline
Start Date
September 30, 2005
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
Conditions
Multiple Sclerosis, Relapsing-Remitting
All Listed Sponsors
lead
Merck KGaA, Darmstadt, Germany
INDUSTRY
NCT01141751 - An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy | Biotech Hunter | Biotech Hunter